He et al.51 showed that overexpression of miR-122 in 5-fluorouracil-resistant colon cancer cells resensitized 5-fluorouracil resistance through the inhibition of PKM2 both in vitro and in vivo, revealing that glycolysis inhibition might be a promising therapeutic strategy to overcome 5-fluorouracil resistance. Here, PKM is linked to colonic neoplasm.